Long Term Pharmacy
Long Term Pharmacy
  • Partnering with Genoa

Partnering with Genoa Healthcare for Assisted Living Pharmacy: PeopleServe (Jackson, Wisc.)

Mar 1st, 2021

Josh McCutcheon, Team Coordinator, PeopleServe, describes how Genoa Healthcare has improved pharmacy care at PeopleServe.

PeopleServe provides home care, living arrangements and residential support to individuals with disabilities in Wisconsin. We started working with Genoa Healthcare to provide pharmacy services to our residents in 2012 and have yet to look back.

Unparalleled customer service

Above all else, Genoa Healthcare exemplifies an unheard of level of customer service. When we pick up the phone we always speak to a real person. Their consulting pharmacists are knowledgeable, professional, and they work seamlessly with our staff.

In fact, when we made the decision to transition to Genoa more than nine years ago, they did an outstanding job during the conversion. Whatever it takes to get the job done, they’re always in lock step with us through the entire process.

The meaning of integrity

We recently had a resident who had a relatively invasive emergency surgery and was potentially going to be hospitalized, which was something our resident didn’t want. Fortunately he was able to come home because we got a hold of Genoa and were able to get his medications after hours in a timely fashion. It was literally just one call to Genoa and we were able to prevent him from having to stay in the hospital overnight.

An integral part of our team

The level of attention, follow-up, and overall service of Genoa is unmatched. Their management is personally involved in the daily operations of their pharmacy teams and more importantly, their employees demonstrate a sense of ownership in their decisions and actions.

I’d recommend Genoa to any assisted living facility that is looking for a high-touch, approachable, and dependable pharmacy partner.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....

  • 340B
Your questions, answered: 340B manufacturer pricing restrictions

Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Currently available and emerging therapy options for treatment-resistant depression

Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...